NVNO Stock — enVVeno Medical Corp: Metrics

Market overview

2 metrics

Share price

$11.30

Market cap

$7.50M

Price action

19 metrics

Price change (1W)

+1.7%

Price change (30D)

+2.6%

Price change (3M)

+2.1%

Price change (6M)

+2.4%

Price change (YTD)

—

Price change (1Y)

—

Trailing year

Price change (5Y)

—

52-week high

—

52-week low

—

Change from 52-week high

—

Change from 52-week low

—

Annualized volatility

80.8%

Beta

0.7

RSI (14D)

51.3

Price vs SMA 50

+1.8%

Price vs SMA 200

—

Avg volume (3M)

16,611

Relative volume

2.5

Average dollar volume

$175,549

Company

3 metrics

Sector

Healthcare

Industry

Medical Devices

Shares outstanding

682,722

Valuation

12 metrics

P / E (TTM)

—

Trailing earnings

PEG ratio

—

EV / revenue

—

EV / EBITDA

—

EV / EBIT

—

P / sales

121.5×

reciprocal yield 0.8%

P / book

0.4

reciprocal yield 275.7%

FCF yield

—

TTM · current market cap

Buyback yield

—

P / FCF

—

P / operating cash flow

—

Earnings yield

-209.8%

Historical valuation

8 metrics

P / E historical average (3Y)

—

P / E historical average (5Y)

—

EV / revenue historical average (3Y)

—

EV / revenue historical average (5Y)

—

EV / EBIT historical average (3Y)

—

EV / EBIT historical average (5Y)

—

EV / EBITDA historical average (3Y)

—

EV / EBITDA historical average (5Y)

—

Dividends & buybacks

7 metrics

Dividend yield

—

Trailing 12 months

Payout ratio

—

Shareholder yield

—

Dividend / share (TTM)

—

Dividend growth YoY

—

Dividend growth streak

—

Last ex-dividend

—

Earnings calendar

2 metrics

Next earnings

—

Last earnings

—

Profitability

9 metrics

Gross margin

—

Operating margin

-24,566.5%

Trailing 12 months

Net margin

-24,406.7%

Gross profit (TTM)

—

Operating profit (TTM)

−$16.75M

Net income (TTM)

−$15.72M

Trailing 12 months

Diluted EPS (TTM)

$-25.05

FCF margin

—

Effective tax rate

—

Per share

11 metrics

Revenue per diluted share (TTM)

—

Gross profit per diluted share (TTM)

—

Operating profit per diluted share (TTM)

—

EBITDA per diluted share (TTM)

—

Net income per diluted share (TTM)

—

Operating cash flow per diluted share (TTM)

—

Free cash flow per diluted share (TTM)

—

Capital expenditures per diluted share (TTM)

—

R&D per diluted share (TTM)

—

Stock compensation per diluted share (TTM)

—

Book value per share

$-1,587.81

Growth

11 metrics

Revenue growth YoY

+0.6%

Year over year

Net income growth YoY

—

Revenue (TTM)

$61,705

Trailing 12 months

EPS growth YoY

—

Shares change YoY

+15.5%

Year over year · more shares

Revenue CAGR (3Y)

—

Revenue CAGR (5Y)

—

EPS CAGR (3Y)

—

EPS CAGR (5Y)

—

FCF CAGR (3Y)

—

FCF CAGR (5Y)

—

Quality

14 metrics

Return on equity

-76.1%

Return on assets

-69.4%

Debt / equity

—

Current ratio

11.7

EBITDA (TTM)

−$19.88M

Free cash flow (TTM)

—

Quick ratio

11.7

Interest coverage

—

Net debt / EBITDA

—

Return on invested capital

—

Trailing 12 months

Net cash

$21.49M

Latest balance sheet

Cash & equivalents

$2.84M

Total assets

$22.66M

Total debt

—

Cash flow & spend

7 metrics

Operating cash flow (TTM)

−$14.62M

Capital expenditures (TTM)

—

R&D (TTM)

$8.72M

SG&A (TTM)

$8.03M

Stock compensation (TTM)

$2.19M

R&D / revenue

—

Stock compensation / revenue

—

Ownership (13F)

3 metrics

13F filers

17

13F filer change QoQ

0

Institutional ownership

13.0%

Short interest

3 metrics

Short interest

3.6%

Latest settlement · 1.3 days to cover

Days to cover

1.3d

Short-squeeze score

58 / 100

Insider activity

2 metrics

Net insider buying (90D)

−$1,443

Insider-sentiment score

—

Risk flags

1 metrics

Going concern

—

NVNO · enVVeno Medical Corp

NVNO metrics

Market overview

Price action

Company

Valuation

Historical valuation

Dividends & buybacks

Earnings calendar

Profitability

Growth

Quality

Cash flow & spend

Ownership (13F)

Short interest

Insider activity

Risk flags

No metrics match that search